Medtronic Revenue 2024

The Medtronic Revenue history

YEAR	REVENUE (undefined USD)	GROSS MARGIN (%)
2029e	40.79	50,52
2028e	39.11	52,68
2027e	35.51	58,02
2027e	37.21	55,38
2026e	35.6	57,88
2026e	35.5	58,04
2025e	33.9	60,77
2024e	32.54	63,32
2023	31.23	65,98
2022	31.69	68,53
2021	30.12	65,62
2020	28.91	67,94
2019	30.56	70,34
2018	29.95	69,82
2017	29.71	68,81
2016	28.83	68,29
2015	20.26	68,86
2014	17.01	74,52
2013	16.59	75,13
2012	16.18	75,97
2011	15.51	76,14
2010	15.39	76,73
2009	14.6	75,90
2008	13.52	74,50
2007	12.3	74,31
2006	11.29	75,07
2005	10.06	75,66
2004	9.09	75,21

Medtronic Aktienanalyse

What does Medtronic do?

Medtronic PLC is a globally leading medical technology company headquartered in Dublin, Ireland. The company was founded in 1949 by Earl Bakken and Palmer Hermundslie and has since developed a comprehensive portfolio of products in the field of medical devices and equipment. Medtronic's business model is focused on meeting the demand for innovative medical technology to improve the quality of life for patients and treat or alleviate diseases and disorders. The company strives to constantly invest in research and development to bring new and improved products to the market. Medtronic offers an extensive range of products that can be used in the fields of cardiology, neuromodulation, spinal surgery, diabetes, hearing aids, surgery, ophthalmology, infection prevention, percutaneous intervention procedures, and more. One of the most well-known product series is the pacemaker, which has been manufactured by Medtronic in a variety of models since 1957. In the field of neuromodulation, Medtronic is a leader in the development of implants that can treat various disorders of the nervous system. This includes deep brain stimulation (DBS) for Parkinson's disease, as well as spinal cord stimulation procedures for chronic pain and neurostimulation procedures for bladder, bowel, and gastrointestinal disorders.. In the field of spinal medicine, Medtronic offers a variety of devices that contribute to the stabilization of the spine and can be implemented through minimally invasive procedures. These include products such as plate systems, cages, spinal stabilizations, chamber drains, medication pumps, and more. In the field of diabetes, Medtronic focuses on the development of insulin pump systems that allow for more precise administration of insulin. The system also includes a sensor that continuously monitors blood sugar levels and can trigger insulin delivery as needed. Medtronic is also known for its efforts in infection prevention, offering products such as antimicrobial catheters, wound care, and hospital hygiene solutions. In addition to its products, the company is also involved in medical education and consulting. As part of these efforts, Medtronic develops training and education programs for physicians and healthcare personnel to enhance techniques and the use of devices and systems. Over the years, Medtronic has expanded its product offering through mergers and acquisitions. Currently, the company employs over 86,000 people in locations across more than 160 countries worldwide. Overall, Medtronic aims to drive innovation in medical technology and enable better healthcare for patients worldwide through its products and services. Medtronic ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Medtronic's Sales Figures

The sales figures of Medtronic originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Medtronic’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Medtronic's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Medtronic’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Medtronic Stock

How much revenue did Medtronic generate this year?

Medtronic has achieved a revenue of 32.54 B USD this year.

How much was the turnover of the company Medtronic compared to the previous year?

The revenue of Medtronic has increased by 4.21% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Medtronic?

The revenue of Medtronic is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Medtronic measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Medtronic so important for investors?

The revenue of Medtronic is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Medtronic pay?

Over the past 12 months, Medtronic paid a dividend of 2.75 USD . This corresponds to a dividend yield of about 3.38 %. For the coming 12 months, Medtronic is expected to pay a dividend of 2.81 USD.

What is the dividend yield of Medtronic?

The current dividend yield of Medtronic is 3.38 %.

When does Medtronic pay dividends?

Medtronic pays a quarterly dividend. This is distributed in the months of July, October, January, April.

How secure is the dividend of Medtronic?

Medtronic paid dividends every year for the past 48 years.

What is the dividend of Medtronic?

For the upcoming 12 months, dividends amounting to 2.81 USD are expected. This corresponds to a dividend yield of 3.46 %.

In which sector is Medtronic located?

Medtronic is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medtronic kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medtronic from 4/12/2024 amounting to 0.69 USD, you needed to have the stock in your portfolio before the ex-date on 3/21/2024.

When did Medtronic pay the last dividend?

The last dividend was paid out on 4/12/2024.

What was the dividend of Medtronic in the year 2023?

In the year 2023, Medtronic distributed 2.67 USD as dividends.

In which currency does Medtronic pay out the dividend?

The dividends of Medtronic are distributed in USD.